rs3859501

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000595160.2(ENSG00000269877):​n.56T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.452 in 255,420 control chromosomes in the GnomAD database, including 27,577 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15486 hom., cov: 30)
Exomes 𝑓: 0.47 ( 12091 hom. )

Consequence

ENSG00000269877
ENST00000595160.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.347

Publications

12 publications found
Variant links:
Genes affected
MIR372 (HGNC:31786): (microRNA 372) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.513 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124904767XR_007067336.1 linkn.69T>G non_coding_transcript_exon_variant Exon 1 of 2
MIR372NR_029865.1 linkn.*201A>C downstream_gene_variant
MIR372unassigned_transcript_3400 n.*240A>C downstream_gene_variant
MIR372unassigned_transcript_3401 n.*204A>C downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000269877ENST00000595160.2 linkn.56T>G non_coding_transcript_exon_variant Exon 1 of 2 3
ENSG00000269877ENST00000775521.1 linkn.45T>G non_coding_transcript_exon_variant Exon 1 of 2
ENSG00000269564ENST00000597420.2 linkn.90-440A>C intron_variant Intron 1 of 1 6
MIR372ENST00000362225.1 linkn.*201A>C downstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.438
AC:
66411
AN:
151662
Hom.:
15483
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.275
Gnomad AMI
AF:
0.536
Gnomad AMR
AF:
0.459
Gnomad ASJ
AF:
0.573
Gnomad EAS
AF:
0.515
Gnomad SAS
AF:
0.407
Gnomad FIN
AF:
0.439
Gnomad MID
AF:
0.611
Gnomad NFE
AF:
0.518
Gnomad OTH
AF:
0.500
GnomAD4 exome
AF:
0.474
AC:
49136
AN:
103640
Hom.:
12091
Cov.:
0
AF XY:
0.470
AC XY:
26500
AN XY:
56422
show subpopulations
African (AFR)
AF:
0.263
AC:
882
AN:
3350
American (AMR)
AF:
0.448
AC:
2928
AN:
6532
Ashkenazi Jewish (ASJ)
AF:
0.540
AC:
1202
AN:
2226
East Asian (EAS)
AF:
0.532
AC:
2935
AN:
5522
South Asian (SAS)
AF:
0.402
AC:
8088
AN:
20140
European-Finnish (FIN)
AF:
0.456
AC:
2036
AN:
4462
Middle Eastern (MID)
AF:
0.598
AC:
183
AN:
306
European-Non Finnish (NFE)
AF:
0.507
AC:
28505
AN:
56252
Other (OTH)
AF:
0.490
AC:
2377
AN:
4850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1185
2370
3556
4741
5926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.438
AC:
66436
AN:
151780
Hom.:
15486
Cov.:
30
AF XY:
0.433
AC XY:
32103
AN XY:
74186
show subpopulations
African (AFR)
AF:
0.275
AC:
11380
AN:
41430
American (AMR)
AF:
0.459
AC:
6977
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
0.573
AC:
1988
AN:
3470
East Asian (EAS)
AF:
0.515
AC:
2633
AN:
5114
South Asian (SAS)
AF:
0.407
AC:
1958
AN:
4816
European-Finnish (FIN)
AF:
0.439
AC:
4621
AN:
10518
Middle Eastern (MID)
AF:
0.599
AC:
176
AN:
294
European-Non Finnish (NFE)
AF:
0.518
AC:
35156
AN:
67914
Other (OTH)
AF:
0.503
AC:
1059
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1833
3666
5499
7332
9165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.499
Hom.:
35070
Bravo
AF:
0.439
Asia WGS
AF:
0.415
AC:
1438
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.5
DANN
Benign
0.63
PhyloP100
0.35

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3859501; hg19: chr19-54291411; API